Shin Nippon Biomedical Laboratories is forecast to grow earnings and revenue by 0.01% and 10.2% per annum respectively. EPS is expected to decline by 0.3% per annum. Return on equity is forecast to be 9.3% in 3 years.
Key information
0.01%
Earnings growth rate
-0.33%
EPS growth rate
Life Sciences earnings growth
17.0%
Revenue growth rate
10.2%
Future return on equity
9.30%
Analyst coverage
Low
Last updated
29 May 2026
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
OTCPK:SBLO.F - Analysts future estimates and past financials data (JPY Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2029
45,044
4,501
-47
7,302
2
3/31/2028
40,960
4,008
-2,484
6,323
2
3/31/2027
38,371
3,950
-4,334
6,237
2
3/31/2026
32,525
4,567
2,991
8,327
N/A
12/31/2025
31,374
3,990
N/A
N/A
N/A
9/30/2025
34,671
4,654
2,088
8,623
N/A
6/30/2025
33,342
5,063
N/A
N/A
N/A
3/31/2025
32,413
4,924
-3,897
7,035
N/A
12/31/2024
30,701
4,942
N/A
N/A
N/A
9/30/2024
27,074
3,896
-11,724
1,650
N/A
6/30/2024
26,195
4,280
N/A
N/A
N/A
3/31/2024
26,450
5,531
-6,498
2,106
N/A
12/31/2023
26,703
5,503
N/A
N/A
N/A
9/30/2023
26,626
4,607
-4,074
1,899
N/A
6/30/2023
26,848
5,489
N/A
N/A
N/A
3/31/2023
25,090
6,060
-950
4,004
N/A
12/31/2022
21,173
6,231
N/A
N/A
N/A
9/30/2022
20,135
8,043
4,382
7,170
N/A
6/30/2022
18,753
7,245
N/A
N/A
N/A
3/31/2022
17,748
7,127
4,339
5,952
N/A
12/31/2021
17,636
7,432
N/A
N/A
N/A
9/30/2021
16,068
6,025
4,075
5,301
N/A
6/30/2021
14,978
4,844
N/A
N/A
N/A
3/31/2021
15,110
3,661
3,629
4,746
N/A
12/31/2020
14,910
2,421
N/A
N/A
N/A
9/30/2020
15,175
2,812
1,389
2,706
N/A
6/30/2020
15,004
3,234
N/A
N/A
N/A
3/31/2020
14,561
2,550
1,788
3,018
N/A
12/31/2019
13,497
1,990
N/A
N/A
N/A
9/30/2019
13,167
1,915
N/A
2,988
N/A
6/30/2019
14,676
1,524
N/A
N/A
N/A
3/31/2019
15,658
1,950
N/A
2,892
N/A
12/31/2018
17,337
-49
N/A
N/A
N/A
9/30/2018
17,928
-993
N/A
2,943
N/A
6/30/2018
16,937
-2,566
N/A
N/A
N/A
3/31/2018
16,600
-3,555
N/A
1,344
N/A
12/31/2017
17,186
-1,072
N/A
N/A
N/A
9/30/2017
17,714
327
N/A
280
N/A
6/30/2017
17,230
260
N/A
N/A
N/A
3/31/2017
17,244
-915
N/A
-849
N/A
12/31/2016
15,880
-1,821
N/A
N/A
N/A
9/30/2016
15,269
-1,273
N/A
-3,109
N/A
6/30/2016
14,922
-1,475
N/A
N/A
N/A
3/31/2016
14,750
2,646
N/A
-3,339
N/A
12/31/2015
15,637
2,060
N/A
N/A
N/A
9/30/2015
16,344
401
N/A
-2,379
N/A
6/30/2015
17,164
1,546
N/A
N/A
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SBLO.F's forecast earnings growth (0.01% per year) is below the savings rate (3.5%).
Earnings vs Market: SBLO.F's earnings (0.01% per year) are forecast to grow slower than the US market (18.5% per year).
High Growth Earnings: SBLO.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: SBLO.F's revenue (10.2% per year) is forecast to grow slower than the US market (12.7% per year).
High Growth Revenue: SBLO.F's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SBLO.F's Return on Equity is forecast to be low in 3 years time (9.3%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/15 03:58
End of Day Share Price
2026/06/09 00:00
Earnings
2026/03/31
Annual Earnings
2026/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shin Nippon Biomedical Laboratories, Ltd. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.